IL30281A - Amidine history and process for their preparation - Google Patents

Amidine history and process for their preparation

Info

Publication number
IL30281A
IL30281A IL30281A IL3028168A IL30281A IL 30281 A IL30281 A IL 30281A IL 30281 A IL30281 A IL 30281A IL 3028168 A IL3028168 A IL 3028168A IL 30281 A IL30281 A IL 30281A
Authority
IL
Israel
Prior art keywords
general formula
hydrogen
compound
comprises reacting
methyl
Prior art date
Application number
IL30281A
Other languages
English (en)
Hebrew (he)
Other versions
IL30281A0 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL30281A0 publication Critical patent/IL30281A0/xx
Publication of IL30281A publication Critical patent/IL30281A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL30281A 1967-07-11 1968-07-01 Amidine history and process for their preparation IL30281A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI000718 1967-07-11

Publications (2)

Publication Number Publication Date
IL30281A0 IL30281A0 (en) 1968-09-26
IL30281A true IL30281A (en) 1971-12-29

Family

ID=10994339

Family Applications (1)

Application Number Title Priority Date Filing Date
IL30281A IL30281A (en) 1967-07-11 1968-07-01 Amidine history and process for their preparation

Country Status (8)

Country Link
US (1) US3663610A (de)
JP (1) JPS4824385B1 (de)
AT (2) AT296960B (de)
CA (1) CA953298A (de)
FR (1) FR7906M (de)
GB (1) GB1238693A (de)
IL (1) IL30281A (de)
NL (1) NL6809615A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021471A (en) * 1974-04-18 1977-05-03 Givaudan Corporation Formamidines useful as ultraviolet light absorbers
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
IT1231238B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati ammidinici
GB8903592D0 (en) * 1989-02-16 1989-04-05 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
JPS4824385B1 (de) 1973-07-20
DE1768787A1 (de) 1972-04-20
NL6809615A (de) 1969-01-14
IL30281A0 (en) 1968-09-26
AT291221B (de) 1971-07-12
DE1768787B2 (de) 1975-09-11
US3663610A (en) 1972-05-16
AT296960B (de) 1972-03-10
CA953298A (en) 1974-08-20
GB1238693A (de) 1971-07-07
FR7906M (de) 1970-05-11

Similar Documents

Publication Publication Date Title
ES8107217A1 (es) Un procedimiento para preparar un compuesto de 1,8-naftiri- dina
CA2011346A1 (en) 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
FI64144C (fi) Foerfarande foer framstaellning av 2-arylamino-2-imidazolinderivat
Black et al. Synthetic studies related to mycobactins. I. Synthesis of 2-(2'-hydroxyphenyl)-2-oxazoline-4-carboxylic acid and related compounds
IL30281A (en) Amidine history and process for their preparation
HU211997B (en) Process to prepare n-methyl-n-(1-naphtyl-methyl)-4-(2-phenyl-propyl)-benzylamine and pharmaceutical compns. contg. it
CH639078A5 (fr) Amides derives d'acides carboxyliques-5 pyrimidiniques, leur preparation et medicaments les contenant.
DK412287D0 (da) Fremgangsmaade til fremstilling af 1-ethyl-6-fluor-7-(4- eventuelt substitueret piperazino)-4-oxo-1,4-dihydro-quinolin-3-carboxylsyrederivater samt ved fremgangsmaaden anvendelige mellem-produkter
DK682288A (da) Fremgangsmaade til fremstilling af quinolincarboxylsyrer
AU2018374838B2 (en) Process for preparing acylated amphetamine derivatives
IE902290L (en) (1,2,3,4-Tetrahydro-9-acridinimino) cyclohexane carboxylic¹acid and related compounds, a process for their preparation¹and their use as medicaments
GB1066613A (en) Naphthalene derivatives
US2586844A (en) Preparation of delta2-1, 3-diazacycloalkenes
BE1004489A3 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant.
GB1008849A (en) Basically substituted triazolidines, processes for their manufacture and pharmaceutical preparations containing them
GB1042296A (en) Novel dibenzoxazepinones, their preparation and compositions containing them
IL29445A (en) Phenoxyisoalkyl imidazolines and their preparation
US3751423A (en) Trichloroethylidene-amino-thiazoles
GB1589752A (en) 5,6-dihydro-3-phenyl-imidazo(5,1-a)isoquinolines
US8809590B2 (en) Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol
GB1046001A (en) Propanolamine derivatives
HU190019B (hu) Eljárás 8-(alkoxi'karbonil-amino)-4-áril-2-metil-tetrahidro -izokinolin-származékok előállítására
GB980593A (en) Novel quinazoline derivatives and a process for the manufacture thereof
CS202088B2 (en) Method of producing tetrameric complex of malonylurea derivatives